Amplimmune Immunology's Acquisition

Amplimmune Immunology was acquired by MedImmune on October 07, 2013.

Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientifi…

Articles about Amplimmune Immunology's Acquisition: